Literature DB >> 26773517

IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.

Gang Xi1, Xinchun Shen2, Clifford J Rosen3, David R Clemmons1.   

Abstract

Insulin like growth factor I (IGF-I) and insulin like growth factor binding protein-2 (IGFBP-2) function coordinately to stimulate AKT and osteoblast differentiation. IGFBP-2 binding to receptor protein tyrosine phosphatase β (RPTPβ) stimulates polymerization and inactivation of phosphatase activity. Because phosphatase and tensin homolog (PTEN) is the primary target of RPTPβ, this leads to enhanced PTEN tyrosine phosphorylation and inactivation. However RPTPβ inactivation also requires IGF-I receptor activation. The current studies were undertaken to determine the mechanism by which IGF-I mediates changes in RPTPβ function in osteoblasts. IGFBP-2/IGF-I stimulated vimentin binding to RPTPβ and this was required for RPTPβ polymerization. Vimentin serine phosphorylation mediated its binding to RPTPβ and PKCζ was identified as the kinase that phosphorylated vimentin. To determine the mechanism underlying IGF-I stimulation of PKCζ-mediated vimentin phosphorylation, we focused on insulin receptor substrate-1 (IRS-1). IGF-I stimulated IRS-1 phosphorylation and recruitment of PKCζ and vimentin to phospho-IRS-1. IRS-1 immunoprecipitates containing PKCζ and vimentin were used to confirm that activated PKCζ directly phosphorylated vimentin. PKCζ does not contain a SH-2 domain that is required to bind to phospho-IRS-1. To determine the mechanism of PKCζ recruitment we analyzed the role of p62 (a PKCζ binding protein) that contains a SH2 domain. Exposure to differentiation medium plus IGF-I stimulated PKCζ/p62 association. Subsequent analysis showed the p62/PKCζ complex was co-recruited to IRS-1. Peptides that disrupted p62/PKCζ or p62/IRS-1 inhibited IGF-I/IGFBP-2 stimulated PKCζ activation, vimentin phosphorylation, PTEN tyrosine phosphorylation, AKT activation, and osteoblast differentiation. The importance of these signaling events for differentiation was confirmed in primary mouse calvarial osteoblasts. These results demonstrate the cooperative interaction between RPTPβ and the IGF-I receptor leading to a coordinated series of signaling events that are required for osteoblast differentiation. Our findings emphasize the important role IRS-1 plays in modulating these signaling events and confirm its essential role in facilitating osteoblast differentiation.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  IRS-1; OSTEOBLAST DIFFERENTIATION; P62; PKCζ; VIMENTIN

Mesh:

Substances:

Year:  2016        PMID: 26773517      PMCID: PMC5228590          DOI: 10.1002/jbmr.2791

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  44 in total

1.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.

Authors:  Kristen E Govoni; Jon E Wergedal; Lore Florin; Peter Angel; David J Baylink; Subburaman Mohan
Journal:  Endocrinology       Date:  2007-08-23       Impact factor: 4.736

2.  Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.

Authors:  Masayuki Yamaguchi; Naoshi Ogata; Yusuke Shinoda; Toru Akune; Satoru Kamekura; Yasuo Terauchi; Takashi Kadowaki; Kazuto Hoshi; Ung-Il Chung; Kozo Nakamura; Hiroshi Kawaguchi
Journal:  Endocrinology       Date:  2005-02-17       Impact factor: 4.736

3.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton.

Authors:  Masanobu Kawai; Anne C Breggia; Victoria E DeMambro; Xinchun Shen; Ernesto Canalis; Mary L Bouxsein; Wesley G Beamer; David R Clemmons; Clifford J Rosen
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

5.  Distinct effects of calcium- and cyclic AMP-enhancing factors on cytoskeletal synthesis and assembly in mouse osteoblastic cells.

Authors:  A Lomri; P J Marie
Journal:  Biochim Biophys Acta       Date:  1990-04-09

6.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

Authors:  V E DeMambro; D R Clemmons; L G Horton; M L Bouxsein; T L Wood; W G Beamer; E Canalis; C J Rosen
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

7.  Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.

Authors:  Sebastio Perrini; Annalisa Natalicchio; Luigi Laviola; Angelo Cignarelli; Mariangela Melchiorre; Francesca De Stefano; Cristina Caccioppoli; Anna Leonardini; Sabina Martemucci; Gaetana Belsanti; Sara Miccoli; Anna Ciampolillo; Ada Corrado; Francesco Paolo Cantatore; Riccardo Giorgino; Francesco Giorgino
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

8.  Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Laura A Maile; Yan Ling; Lee M Graves; David R Clemmons
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

9.  Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase.

Authors:  L M Chuang; M G Myers; J M Backer; S E Shoelson; M F White; M J Birnbaum; C R Kahn
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

View more
  11 in total

1.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

2.  Protein Scaffolds Control Localized Protein Kinase Cζ Activity.

Authors:  Irene S Tobias; Alexandra C Newton
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

Review 3.  Exercise and Diet: Uncovering Prospective Mediators of Skeletal Fragility in Bone and Marrow Adipose Tissue.

Authors:  Sarah E Little-Letsinger; Gabriel M Pagnotti; Cody McGrath; Maya Styner
Journal:  Curr Osteoporos Rep       Date:  2020-10-17       Impact factor: 5.096

Review 4.  The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases.

Authors:  Fei Song; Xiao-Xia Zhou; Yu Hu; Gang Li; Yan Wang
Journal:  Adv Ther       Date:  2020-12-17       Impact factor: 3.845

5.  IGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition.

Authors:  Tao Qiu; Janet L Crane; Liang Xie; Lingling Xian; Hui Xie; Xu Cao
Journal:  Bone Res       Date:  2018-02-26       Impact factor: 13.567

Review 6.  Insulin- like Growth Factor-Binding Protein Action in Bone Tissue: A Key Role for Pregnancy- Associated Plasma Protein-A.

Authors:  James Beattie; Hasanain Al-Khafaji; Pernille R Noer; Hanaa Esa Alkharobi; Aishah Alhodhodi; Josephine Meade; Reem El-Gendy; Claus Oxvig
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-16       Impact factor: 5.555

7.  Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.

Authors:  Wishrawana S Ratnayake; André H Apostolatos; David A Ostrov; Mildred Acevedo-Duncan
Journal:  Int J Oncol       Date:  2017-09-22       Impact factor: 5.650

8.  Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors.

Authors:  Wishrawana S Ratnayake; Christopher A Apostolatos; André H Apostolatos; Ryan J Schutte; Monica A Huynh; David A Ostrov; Mildred Acevedo-Duncan
Journal:  Cell Adh Migr       Date:  2018-05-21       Impact factor: 3.405

9.  Quantitative iTRAQ-based proteomic analysis of differentially expressed proteins in aging in human and monkey.

Authors:  Hao Wang; Xiaoqi Zhu; Junyan Shen; En-Feng Zhao; Dajun He; Haitao Shen; Hailiang Liu; Yongxin Zhou
Journal:  BMC Genomics       Date:  2019-10-11       Impact factor: 3.969

10.  Exosomes Derived From M2 Macrophages Facilitate Osteogenesis and Reduce Adipogenesis of BMSCs.

Authors:  Ziyi Li; Yafei Wang; Shilun Li; Yukun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.